Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 952 of 5804
-
Promising drug cocktail targets tough childhood cancers
Disease control Not yet recruitingHEM-iSMART is a master protocol which investigates multiple investigational medicinal products in children, adolescents and young adults (AYA) with relapsed/refractory (R/R) ALL and LBL. Sub-protocol E is a phase I/II trial evaluating the safety and efficacy of capivasertib + ven…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
New trial aims to stop stomach bleeding before it starts
Disease control Not yet recruitingA number of treatment modalities are currently in use for gastric variceal bleeding (GVB). Balloon-occluded, plug-assisted, and coil-assisted retrograde transvenous obliteration (RTO) procedures are described in the literature as treatments for GVB after a bleeding episode occurs…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New antibody drug aims to tame Hard-to-Treat kidney disease
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics(PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of YK012 in participants with primary membranous nephropathy (pMN).
Phase: PHASE1 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis is a parallel arm non-randomized dose-escalation, open-label basket exploratory phase 1 clinical trial where Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS) and Leber's hereditary optic neuropathy-Plus (LHON-Plus) participants will undergo simulta…
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New polymer plug aims to prevent deadly aortic growth in first human trial
Disease control Not yet recruitingTo determine the safety and feasibility of investigational product to reduce aortic dissection false lumen perfusion.
Phase: NA • Sponsor: Shape Memory Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a bile acid and herbal mix treat Diabetes-Related vision loss?
Disease control Not yet recruitingDiabetic macular edema is seen in the later stages of diabetic retinopathy with current conventional therapies targeting local vascular dysfunction. These therapies provide transient improvement in vision and are often uncomfortable to persons with diabetic macular edema and fina…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New vaccine aims to halt ovarian cancer recurrence detected in blood
Disease control Not yet recruitingThis phase II trial studies how well giving the insulin-like growth factor binding protein 2 \[pUMVC3-hIGFBP-2 multi-epitope plasmid deoxyribonucleic acid (DNA) (IGFBP-2)\] vaccine after one dose of carboplatin works to stop ovarian cancer from growing, spreading, or getting wors…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug trial targets rare nasal cancer
Disease control Not yet recruitingThe goal of this clinical research study is to learn if zanzalintinib can help to control recurrent/metastatic ONB. The safety of zanzalintinib will also be studied.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New shot aims to clear stubborn HPV infection in women
Disease control Not yet recruitingThis is a two-part, phase I/IIa study, intended to evaluate the safety, tolerability, immunogenicity, and efficacy of NWRD09 in female participants with persistent HPV16 infection, and to determine the MTD, and/or RP2D of NWRD09.
Phase: PHASE1, PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug cocktail targets tough leukemia
Disease control Not yet recruitingThe purpose of this research study is to see if a drug called LP-118 is safe and effective for treating adults with Philadelphia chromosome-positive (Ph+) B cell acute lymphoblastic leukemia (ALL), when given with ponatinib, dexamethasone, methotrexate and blinatumomab (the stand…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Veterans' skin cancer risk may be cut by simple clinic procedures
Prevention Not yet recruitingThe investigators' previous studies demonstrate geriatric subject skin responds differently to ultraviolet B (UVB) light compared to young subject skin, which contribute to increased rates of nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) development in geriatric popul…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops could bring relief to millions with chronic dry eye
Symptom relief Not yet recruitingProspective, multicenter, randomized, vehicle-controlled, double-masked, study of CAM-101 topical ophthalmic solution compared to vehicle control followed by crossover to long-term follow-up open-label treatment with CAM-101 for one year.
Phase: PHASE3 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Sauna therapy could slash antibiotic use in chronic lung disease
Disease control Not yet recruitingThe aim of this study is to determine whether an intervention with frequent thermotherapy will be able to reduce the amount of colonizing bacteria in the bronchoalveolar lavage sample and eradicate the colonizing bacteria.
Phase: NA • Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a growth factor infusion help women with thin uterine lining get pregnant?
Disease control Not yet recruitingThin endometrium is a condition in which the lining of the uterus is too thin during preparation for embryo transfer. This may reduce the chance of pregnancy and live birth in patients undergoing frozen-thawed embryo transfer. This study will evaluate whether intrauterine infusi…
Phase: PHASE3 • Sponsor: Nanjing University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Singing and song may ease Dementia's toll on patients and caregivers
Symptom relief Not yet recruitingThe goal of this single arm interventional, pre-post study is to learn about the feasibility and impact of group music therapy sessions for people living with dementia in two different community settings. This research will answer the following questions: 1. What is the impact …
Phase: NA • Sponsor: Anglia Ruskin University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could finding meaning ease depression and anxiety?
Symptom relief Not yet recruitingYoung adults who experience depression and/or anxiety symptoms (i.e., internalizing symptoms) will be randomly allocated to a six-session meaning-centered intervention condition or a waitlist condition. Both conditions receive the same questionnaires at baseline, post assessment …
Phase: NA • Sponsor: University of Groningen • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can a therapy that tackles both PTSD and everyday stress help those most at risk?
Symptom relief Not yet recruitingPopulations facing health disparities include groups with significantly higher rates of posttraumatic stress disorder than the general population who frequently experience lived experience stress, which may complicate posttraumatic stress disorder symptom presentations. However, …
Phase: NA • Sponsor: Boston University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Gut and mouth bacteria may predict who benefits from probiotics for gum disease
Disease control Not yet recruitingProbiotics are live microorganisms that can be taken as supplements and have shown promise in playing a beneficial role in improving clinical conditions that are characterized by chronic inflammation, such as periodontal disease (PD). The human gut microbiome is composed of trill…
Phase: NA • Sponsor: University of New Hampshire • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can an old alcohol-dependence drug help the immune system fight brain cancer?
Disease control Not yet recruitingThis research study is for participants with glioblastoma. It can cause a tumor immunosuppression which helps myeloid cells that can stop T-cell function. Disulfiram is a drug that has been used in treating other disorders, but this study will examine if disulfiram can help make …
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a smartphone app help prevent cancer? a new trial tests personalised lifestyle coaching.
Prevention Not yet recruitingThe aim of this clinical trial is to find out whether CANVIA can help adults improve dietary and lifestyle habits related to cancer prevention. CANVIA is a personalised programme based on cancer prevention recommendations from the World Cancer Research Fund and the American Insti…
Phase: NA • Sponsor: Fundació d'investigació Sanitària de les Illes Balears • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC